Latest Capital Raises News

Page 73 of 767
Southern Palladium reported a doubling in chromite recoveries at its Bengwenyama project, prompting a redesign of the processing plant and pushing the DFS completion to late Q4 2026 amid drilling delays and enhanced metallurgical work.
Maxwell Dee
Maxwell Dee
29 Apr 2026
Rokeby Resources bolsters its portfolio with the acquisition of the high-grade Omeo Gold Project in Victoria, while unveiling promising exploration results at its Queensland assets and planning a delayed drilling campaign. The company has secured $4 million in capital commitments and announced key leadership changes.
Maxwell Dee
Maxwell Dee
29 Apr 2026
Cosmos Exploration is advancing its Bolivian lithium ambitions by exercising its option to acquire 100% of EAU Lithium and raising A$5 million to fund exploration and acquisition costs.
Maxwell Dee
Maxwell Dee
29 Apr 2026
HyTerra Ltd is progressing its flagship Nemaha hydrogen project with a key production test planned for Q2 2026, while expanding its global footprint through strategic partnerships and a $7 million capital raise.
Maxwell Dee
Maxwell Dee
29 Apr 2026
Botanix Pharmaceuticals reported a 5% rise in Sofdra prescriptions in Q3 FY26 despite a dip in net revenue due to insurance deductible resets, strengthened by a $45 million capital raise and a new API supply deal with Piramal.
Ada Torres
Ada Torres
29 Apr 2026
Omega Oil and Gas has secured a commanding acreage position in Queensland’s Taroom Trough and fully funded an expanded drilling program to accelerate appraisal and early production.
Maxwell Dee
Maxwell Dee
29 Apr 2026
Sky Metals has bolstered its cash reserves with a $20.5 million raise, backing a major drilling push at Tallebung and expanding exploration at Doradilla, positioning both projects for significant resource growth and development progress.
Maxwell Dee
Maxwell Dee
29 Apr 2026
Syrah Resources delivered a record 24kt graphite production at Balama and secured US$72 million in equity to support medium-term ramp-up and Vidalia commercialisation, navigating a complex US trade environment.
Maxwell Dee
Maxwell Dee
29 Apr 2026
Avecho Biotechnology has exceeded its Phase III CBD insomnia trial recruitment target by 16%, setting the stage for a more robust interim analysis scheduled for June 2026. The company’s commercial partnership with Sandoz AG and strengthened patent portfolio underpin its Australian market strategy.
Ada Torres
Ada Torres
29 Apr 2026
Prospect Resources has delivered further gold assay results from its Nyungu Central deposit, reinforcing the potential for valuable by-product credits at the Mumbezhi Copper Project and setting the stage for an aggressive Phase 3 drilling campaign.
Maxwell Dee
Maxwell Dee
29 Apr 2026
TrivarX appoints Dr Danielle Meyrick as CEO to spearhead clinical trials and commercialisation of its novel stable isotope MRI brain cancer imaging platform, with Phase 1 studies on track for completion this year.
Ada Torres
Ada Torres
29 Apr 2026
Mamba Exploration has secured a controlling stake in the Meeka East Gold Project, bolstered by a $2 million capital raise and promising early exploration work including extensive soil sampling and historic data validation.
Maxwell Dee
Maxwell Dee
29 Apr 2026